CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Trio Medicines against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Gastrin Antagonists (Eg Yf476, Netazepide) For Treatment And Prevention Of OsteoporosisCL BIOSCIENCESNov 17, 2021

Top competitors of Trio Medicines

List of top competitors of Trio Medicines based on patent oppositions.